CSL Behring has identified what it will take to win in a major autoimmune market. Ahead of a potential approval of argenx’s rival drug, the company surveyed people with chronic inflammatory ...

I exist pretty far on one side of the spectrum when it comes to how hardcore I want a road car to be. I like manual everything; I want to be able to turn any computer assistance off, even if it's just ...

The new M4 CSL is a 543-horsepower track junkie weighing in at 3,640 pounds, after losing a rather heavy passenger’s worth of weight through clever engineering and material upgrades. For those of you ...

BMW M is celebrating its 50th anniversary this year and we can’t think of a better way to mark the occasion than the announcement of a new M4 CSL (Competition Sport Lightweight). While the M3 ...

With a new CEO, a new subsidiary, a newly approved gene therapy and three R&D centers under construction on three different continents, change is coming fast for CSL Limited. Established more than a ...

SYDNEY—Vaccine and blood-products company CSL on Tuesday unveiled a sweeping corporate restructure that will include spinning off its flu-vaccine unit Seqirus and cutting up to 15% of its staff.

If there’s one car that deserves to be called the Holy Grail of BMW 3 Series, it’s the 2004 BMW M3 CSL. The rare, lightweight coupe isn’t the kind of car you’d expect to be forgotten for years in a ...

It's BMW's 50th this year, and to celebrate, the German automaker will put a special anniversary-edition BMW Roundel badge on the hood of the new 2023 BMW M4 CSL. Oh yeah, they also gutted 240 pounds ...

When Fanatec revealed last year that it was bringing a direct drive wheel base to market for just $350, sim racers sort of lost it. Direct drive is the cream of the crop in terms of force feedback ...

CSL (ASX:CSL) has attracted fresh attention after its Broadmeadows plasma fractionation facility in Australia was named the Overall Winner of the 2025 Facility of the Year Award by the International ...

CSL is laying off up to 15% of its workforce as the Australian pharma looks to cut R&D costs and spin out its vaccine subsidiary in a wide-ranging restructure. The Melbourne-headquartered company will ...